Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Novel technologies were developed and used for the synthesis and evaluation of new triazolopyridazine BRD9 inhibitors.

Original publication

DOI

10.1039/c4md00007b

Type

Journal article

Journal

Med. Chem. Commun.

Publisher

Royal Society of Chemistry (RSC)

Publication Date

2014

Volume

5

Pages

540 - 546